AAAAAA

   
Results: 1-25 | 26-50 | 51-57
Results: 26-50/57
PAPILLOMAVIRUS ONCOPROTEINS AS VACCINE CANDIDATES
Authors: GALLOWAY DA
Citation: Da. Galloway, PAPILLOMAVIRUS ONCOPROTEINS AS VACCINE CANDIDATES, Lancet, 347(9014), 1996, pp. 1498-1499
SURFACE CONFORMATIONAL AND LINEAR EPITOPES ON HPV-16 AND HPV-18 L1 VIRUS-LIKE PARTICLES AS DEFINED BY MONOCLONAL-ANTIBODIES
Authors: CHRISTENSEN ND DILLNER J EKLUND C CARTER JJ WIPF GC REED CA CLADEL NM GALLOWAY DA
Citation: Nd. Christensen et al., SURFACE CONFORMATIONAL AND LINEAR EPITOPES ON HPV-16 AND HPV-18 L1 VIRUS-LIKE PARTICLES AS DEFINED BY MONOCLONAL-ANTIBODIES, Virology, 223(1), 1996, pp. 174-184
ABROGATION OF GROWTH ARREST SIGNALS BY HUMAN PAPILLOMAVIRUS TYPE-16 E7 IS MEDIATED BY SEQUENCES REQUIRED FOR TRANSFORMATION
Authors: DEMERS GW ESPLING E HARRY JB ETSCHEID BG GALLOWAY DA
Citation: Gw. Demers et al., ABROGATION OF GROWTH ARREST SIGNALS BY HUMAN PAPILLOMAVIRUS TYPE-16 E7 IS MEDIATED BY SEQUENCES REQUIRED FOR TRANSFORMATION, Journal of virology, 70(10), 1996, pp. 6862-6869
THE NATURAL-HISTORY OF HUMAN PAPILLOMAVIRUS TYPE-16 CAPSID ANTIBODIESAMONG A COHORT OF UNIVERSITY WOMEN
Authors: CARTER JJ KOUTSKY LA WIPF GC CHRISTENSEN ND LEE SK KUYPERS J KIVIAT N GALLOWAY DA
Citation: Jj. Carter et al., THE NATURAL-HISTORY OF HUMAN PAPILLOMAVIRUS TYPE-16 CAPSID ANTIBODIESAMONG A COHORT OF UNIVERSITY WOMEN, The Journal of infectious diseases, 174(5), 1996, pp. 927-936
INACTIVATION OF P53 ENHANCES SENSITIVITY TO MULTIPLE CHEMOTHERAPEUTIC-AGENTS
Authors: HAWKINS DS DEMERS GW GALLOWAY DA
Citation: Ds. Hawkins et al., INACTIVATION OF P53 ENHANCES SENSITIVITY TO MULTIPLE CHEMOTHERAPEUTIC-AGENTS, Cancer research, 56(4), 1996, pp. 892-898
LONG-TERM CULTURE AND IMMORTALIZATION OF EPITHELIAL-CELLS FROM NORMALADULT HUMAN PANCREATIC DUCTS TRANSFECTED BY THE E6E7 GENE OF HUMAN PAPILLOMA-VIRUS-16
Authors: FURUKAWA T DUGUID WP ROSENBERG L VIALLET J GALLOWAY DA TSAO MS
Citation: T. Furukawa et al., LONG-TERM CULTURE AND IMMORTALIZATION OF EPITHELIAL-CELLS FROM NORMALADULT HUMAN PANCREATIC DUCTS TRANSFECTED BY THE E6E7 GENE OF HUMAN PAPILLOMA-VIRUS-16, The American journal of pathology, 148(6), 1996, pp. 1763-1770
DIAGNOSIS OF HUMAN PAPILLOMAVIRUS INFECTION BY DETECTION OF VIRAL-DNAAND BY SEROLOGY
Authors: GALLOWAY DA CARTER JJ WIPF G HAGENSEE ME LI LF LEE SK KUYPERS J WATTS DH HOLMES KK KOUTSKY LA KIVIAT N
Citation: Da. Galloway et al., DIAGNOSIS OF HUMAN PAPILLOMAVIRUS INFECTION BY DETECTION OF VIRAL-DNAAND BY SEROLOGY, Journal of cellular biochemistry, 1995, pp. 251-251
IMMUNIZATION OF MICE WITH HPV VACCINIA VIRUS RECOMBINANTS GENERATES SERUM IGG, IGM, AND MUCOSAL IGA ANTIBODIES
Authors: HAGENSEE ME CARTER JJ WIPF GC GALLOWAY DA
Citation: Me. Hagensee et al., IMMUNIZATION OF MICE WITH HPV VACCINIA VIRUS RECOMBINANTS GENERATES SERUM IGG, IGM, AND MUCOSAL IGA ANTIBODIES, Virology, 206(1), 1995, pp. 174-182
CREATING A MELANOCYTE CELL-LINE
Authors: LEPOOLE IC DAS PK VANDENWIJNGAARD MJGJ GALLOWAY DA VANAMSTEL PJ SMIT L SMITS HL VANDENBERG FM WESTERHOF W
Citation: Ic. Lepoole et al., CREATING A MELANOCYTE CELL-LINE, Journal of investigative dermatology, 104(4), 1995, pp. 664-664
ANALYSIS OF HUMAN PAPILLOMAVIRUS TYPE-16 VARIANTS INDICATES ESTABLISHMENT OF PERSISTENT INFECTION
Authors: XI LF DEMERS GW KOUTSKY LA KIVIAT NB KUYPERS J WATTS DH HOLMES KK GALLOWAY DA
Citation: Lf. Xi et al., ANALYSIS OF HUMAN PAPILLOMAVIRUS TYPE-16 VARIANTS INDICATES ESTABLISHMENT OF PERSISTENT INFECTION, The Journal of infectious diseases, 172(3), 1995, pp. 747-755
USE OF HUMAN PAPILLOMAVIRUS TYPE-6 CAPSIDS TO DETECT ANTIBODIES IN PEOPLE WITH GENITAL WARTS
Authors: CARTER JJ WIPF GC HAGENSEE ME MCKNIGHT B HABEL LA LEE SK KUYPERS J KIVIAT N DALING JR KOUTSKY LA WATTS DH HOLMES KK GALLOWAY DA
Citation: Jj. Carter et al., USE OF HUMAN PAPILLOMAVIRUS TYPE-6 CAPSIDS TO DETECT ANTIBODIES IN PEOPLE WITH GENITAL WARTS, The Journal of infectious diseases, 172(1), 1995, pp. 11-18
SEROLOGICAL AND MOLECULAR EVIDENCE OF RHESUS PAPILLOMAVIRUS TYPE-1 INFECTIONS IN TISSUES FROM GEOGRAPHICALLY DISTINCT INSTITUTIONS
Authors: OSTROW RS COUGHLIN SM MCGLENNEN RC JOHNSON AN RATTERREE MS SCHEFFLER J YAEGASHI N GALLOWAY DA FARAS AJ
Citation: Rs. Ostrow et al., SEROLOGICAL AND MOLECULAR EVIDENCE OF RHESUS PAPILLOMAVIRUS TYPE-1 INFECTIONS IN TISSUES FROM GEOGRAPHICALLY DISTINCT INSTITUTIONS, Journal of General Virology, 76, 1995, pp. 293-299
ABROGATION OF THE G(2) CHECKPOINT RESULTS IN DIFFERENTIAL RADIOSENSITIZATION OF G(1) CHECKPOINT-DEFICIENT AND G(1) CHECKPOINT-COMPETENT CELLS
Authors: RUSSELL KJ WIENS LW DEMERS GW GALLOWAY DA PLON SE GROUDINE M
Citation: Kj. Russell et al., ABROGATION OF THE G(2) CHECKPOINT RESULTS IN DIFFERENTIAL RADIOSENSITIZATION OF G(1) CHECKPOINT-DEFICIENT AND G(1) CHECKPOINT-COMPETENT CELLS, Cancer research, 55(8), 1995, pp. 1639-1642
DEFECTIVE G(2) CHECKPOINT FUNCTION IN CELLS FROM INDIVIDUALS WITH FAMILIAL CANCER SYNDROMES
Authors: PAULES RS LEVEDAKOU EN WILSON SJ INNES CL RHODES N TLSTY TD GALLOWAY DA DONEHOWER LA TAINSKY MA KAUFMANN WK
Citation: Rs. Paules et al., DEFECTIVE G(2) CHECKPOINT FUNCTION IN CELLS FROM INDIVIDUALS WITH FAMILIAL CANCER SYNDROMES, Cancer research, 55(8), 1995, pp. 1763-1773
P21(CIP1) IS NOT REQUIRED FOR THE EARLY G(2) CHECKPOINT RESPONSE TO IONIZING-RADIATION
Authors: LEVEDAKOU EN KAUFMANN WK ALCORTA DA GALLOWAY DA PAULES RS
Citation: En. Levedakou et al., P21(CIP1) IS NOT REQUIRED FOR THE EARLY G(2) CHECKPOINT RESPONSE TO IONIZING-RADIATION, Cancer research, 55(12), 1995, pp. 2500-2502
RISK OF VULVAR CANCER-ASSOCIATED WITH HPV-16 L1 ANTIBODY AND SMOKING
Authors: MADELEINE MM DALING JR CARTER JJ HAGENSEE ME WIPF GC GALLOWAY DA MCKNIGHT B
Citation: Mm. Madeleine et al., RISK OF VULVAR CANCER-ASSOCIATED WITH HPV-16 L1 ANTIBODY AND SMOKING, American journal of epidemiology, 141(11), 1995, pp. 78-78
PAPILLOMAVIRUS CAPSIDS - A NEW APPROACH TO IDENTIFY SEROLOGICAL MARKERS OF HPV INFECTION
Authors: GALLOWAY DA
Citation: Da. Galloway, PAPILLOMAVIRUS CAPSIDS - A NEW APPROACH TO IDENTIFY SEROLOGICAL MARKERS OF HPV INFECTION, Journal of the National Cancer Institute, 86(7), 1994, pp. 474-475
HUMAN PAPILLOMAVIRUS VACCINES - A WARTY PROBLEM
Authors: GALLOWAY DA
Citation: Da. Galloway, HUMAN PAPILLOMAVIRUS VACCINES - A WARTY PROBLEM, Infectious agents and disease, 3(4), 1994, pp. 187-193
CELL-CYCLE CHECKPOINT CONTROL IS BYPASSED BY HUMAN PAPILLOMAVIRUS ONCOGENES
Authors: GALLOWAY DA DEMERS GW FOSTER SA HALBERT CL RUSSELL K
Citation: Da. Galloway et al., CELL-CYCLE CHECKPOINT CONTROL IS BYPASSED BY HUMAN PAPILLOMAVIRUS ONCOGENES, Cold Spring Harbor Symposia on Quantitative Biology, 59, 1994, pp. 297-306
THE E6 PROTEIN OF HUMAN PAPILLOMAVIRUS TYPE-16 FUNCTIONS AS A TRANSCRIPTIONAL REPRESSOR IN A MECHANISM INDEPENDENT OF THE TUMOR-SUPPRESSOR PROTEIN, P53
Authors: ETSCHEID BG FOSTER SA GALLOWAY DA
Citation: Bg. Etscheid et al., THE E6 PROTEIN OF HUMAN PAPILLOMAVIRUS TYPE-16 FUNCTIONS AS A TRANSCRIPTIONAL REPRESSOR IN A MECHANISM INDEPENDENT OF THE TUMOR-SUPPRESSOR PROTEIN, P53, Virology, 205(2), 1994, pp. 583-585
USE OF HPV-1 CAPSIDS PRODUCED BY RECOMBINANT VACCINIA VIRUSES IN AN ELISA TO DETECT SERUM ANTIBODIES IN PEOPLE WITH FOOT WARTS
Authors: CARTER JJ HAGENSEE MB LEE SK MCKNIGHT B KOUTSKY LA GALLOWAY DA
Citation: Jj. Carter et al., USE OF HPV-1 CAPSIDS PRODUCED BY RECOMBINANT VACCINIA VIRUSES IN AN ELISA TO DETECT SERUM ANTIBODIES IN PEOPLE WITH FOOT WARTS, Virology, 199(2), 1994, pp. 284-291
ELEVATED WILD-TYPE P53 PROTEIN-LEVELS IN HUMAN EPITHELIAL-CELL LINES IMMORTALIZED BY THE HUMAN PAPILLOMAVIRUS TYPE-16 E7 GENE
Authors: DEMERS GW HALBERT CL GALLOWAY DA
Citation: Gw. Demers et al., ELEVATED WILD-TYPE P53 PROTEIN-LEVELS IN HUMAN EPITHELIAL-CELL LINES IMMORTALIZED BY THE HUMAN PAPILLOMAVIRUS TYPE-16 E7 GENE, Virology, 198(1), 1994, pp. 169-174
GROWTH ARREST BY INDUCTION OF P53 IN DNA DAMAGED KERATINOCYTES IS BYPASSED BY HUMAN PAPILLOMAVIRUS-16 E7
Authors: DEMERS GW FOSTER SA HALBERT CL GALLOWAY DA
Citation: Gw. Demers et al., GROWTH ARREST BY INDUCTION OF P53 IN DNA DAMAGED KERATINOCYTES IS BYPASSED BY HUMAN PAPILLOMAVIRUS-16 E7, Proceedings of the National Academy of Sciences of the United Statesof America, 91(10), 1994, pp. 4382-4386
THE ABILITY OF HUMAN PAPILLOMAVIRUS E6 PROTEINS TO TARGET P53 FOR DEGRADATION IN-VIVO CORRELATES WITH THEIR ABILITY TO ABROGATE ACTINOMYCIND-INDUCED GROWTH ARREST
Authors: FOSTER SA DEMERS GW ETSCHEID BG GALLOWAY DA
Citation: Sa. Foster et al., THE ABILITY OF HUMAN PAPILLOMAVIRUS E6 PROTEINS TO TARGET P53 FOR DEGRADATION IN-VIVO CORRELATES WITH THEIR ABILITY TO ABROGATE ACTINOMYCIND-INDUCED GROWTH ARREST, Journal of virology, 68(9), 1994, pp. 5698-5705
3-DIMENSIONAL STRUCTURE OF VACCINIA VIRUS-PRODUCED HUMAN PAPILLOMAVIRUS TYPE-1 CAPSIDS
Authors: HAGENSEE ME OLSON NH BAKER TS GALLOWAY DA
Citation: Me. Hagensee et al., 3-DIMENSIONAL STRUCTURE OF VACCINIA VIRUS-PRODUCED HUMAN PAPILLOMAVIRUS TYPE-1 CAPSIDS, Journal of virology, 68(7), 1994, pp. 4503-4505
Risultati: 1-25 | 26-50 | 51-57